OncoGenex Announces Publication of Custirsen Phase II Clinical and Pre-Clinical Data in Leading Cance... (tify opportunities to block these mechan...)

OncoGenex Announces Publication of Custirsen Phase II Clinical and Pre-Clinical Data in Leading Cancer Journals

Date:9/6/2011

tify opportunities to block these mechanisms in order to delay tumor progression."

The abstract can be found at the following link:

http://cancerres.aacrjournals.org/content/71/17/5838.abstract

About Custirsen

Custirsen is the only compound currently in development designed to inhibit the production of clusterin, a protein commonly over-produced in cancer cells, and one cause of treatment resistance. Unlike opioids or agents that target the androgen receptor, custirsen is mechanistically unique in its ability to impact pain responses via the regulation of NF-kB (nuclear factor kappa-light-chain-enhancer of activated B cells) activity. This is a potential attribute that could contribute to custirsen's clinical benefit in combination with numerous anti-cancer treatments.

Custirsen has received Fast Track designation from the U.S. Food and Drug Administration (FDA).

More information is available at www.OncoGenex.com and www.tevapharm.com/research.

About OncoGenex Pharmaceuticals

OncoGenex is a biopharmaceutical company committed to the development and commercialization of new cancer therapies that address treatment resistance in cancer patients. OncoGenex has a diverse oncology pipeline, with each product candidate having a distinct mechanism of action and representing a unique opportunity for cancer drug development. OncoGenex and Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) have entered a global collaboration and license agreement to develop and commercialize OncoGenex' lead drug candidate, custirsen. Custirsen is currently in Phase III clinical development as a treatment in men with metastatic castrate-resistant prostate cancer. The companies plan to begin Phase III development of custi
'/>"/>

SOURCE OncoGenex Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Post Your Comments:

(Date:6/18/2013)... 18, 2013 The Pistoia ... the HELM biomolecular representation standard software toolkit and ... HELM (Hierarchical Editing Language for Macromolecules) ... biomolecules (e.g. proteins, nucleotides, antibody drug conjugates) whose ... informatics methodologies impractical or unusable. HELM solves this ...

(Date:6/18/2013)... , June 18, 2013 ... international investment research firm, announces the initiation ... a French biopharmaceutical company developing and marketing ... care indications. (Logo: http://photos.prnewswire.com/prnh/20130417/608168) ... comprehensive report examining the investment merits of ...

(Date:6/18/2013)... -- The "Bioinformatics Market By Sector (Molecular Medicine, Agriculture, ... Data Analysis Services) & Application (Genomics, Proteomics & Drug Design) - Global ... Restraints, and Opportunities in North America , ... and Rest of World. Browse , ... Figures 364 Pages and an in-depth ...

(Date:6/18/2013)... , June 18, 2013 Techne Corporation (NASDAQ: ... it has agreed to acquire 100% ownership of ... Inc. (Bionostics). Bionostics is a global leader in ... that verify the proper operation of in ... point of care blood glucose and blood gas ...

Breaking Biology Technology:The Pistoia Alliance Releases HELM Biomolecular Representation Standard Open Source Tools 2 Edison Expands French Healthcare Sector Coverage With Initiation of Coverage on BioAlliance Pharma 2 Edison Expands French Healthcare Sector Coverage With Initiation of Coverage on BioAlliance Pharma 3 Bioinformatics Market Worth $7.5 Billion by 2017 2 Bioinformatics Market Worth $7.5 Billion by 2017 3 Techne Corporation Announces Acquisition Agreement 2 Techne Corporation Announces Acquisition Agreement 3 Techne Corporation Announces Acquisition Agreement 4 Techne Corporation Announces Acquisition Agreement 5

[0] The Pistoia Alliance Releases HELM Biomolecular Representation Standard Open Source Tools [0] Edison Expands French Healthcare Sector Coverage With Initiation of Coverage on BioAlliance Pharma [0] Bioinformatics Market Worth $7.5 Billion by 2017 [0] Techne Corporation Announces Acquisition Agreement

... YORK , July 7 Reportlinker.com announces that a new market ... , , ... , , , ... , , ...

... July 9, 2010 Federico Capasso, Robert L. Wallace ... Fellow in Electrical Engineering at the Harvard School of ... 2010 Berthold Leibinger Zukunftspreis (the future prize), an international ... of laser light. The prize, consisting of 30,000, ...

... July 6 /PRNewswire/ - Ocean Nutrition Canada Limited - Long time ... make way for a new CEO to lead the company,s next growth phase, ... , , ... food industry veteran, has been appointed as the new President and CEO at ...

Building Biotech Technology Transfer Opportunities: Sponsor and Developer Strategies for Success Laser pioneer Federico Capasso awarded Berthold Leibinger Zukunftspreis New President and CEO appointed at Ocean Nutrition Canada Limited

(Date:6/19/2013)... across the Midwest are expected to contribute to a ... "dead zone," according to a University of Michigan ecologist ... with one for the Chesapeake Bay. , The Gulf ... and Atmospheric Administration, calls for an oxygen-depleted, or hypoxic, ... would place it among the 10 largest on record. ...

(Date:6/18/2013)... June 19, 2013 Paris Air Show – ... Test Systems) , a leading provider of innovative ... is demonstrating its solutions this week at the ... With growing challenges including increasingly complex armament systems ... feature-rich, specialized aerospace test solutions that address legacy ...

(Date:6/18/2013)... UT Arlington environmental engineer has been awarded a ... to ensure water quality and flow in the ... , Andrew Kruzic, UT Arlington associate professor of ... locations to add monochloramine to the water in ... new pump stations and pipelines. Adding monochloramine is ...

Breaking Biology News(10 mins):U-M researcher and colleagues predict possible record-setting Gulf of Mexico 'dead zone' 2 U-M researcher and colleagues predict possible record-setting Gulf of Mexico 'dead zone' 3 U-M researcher and colleagues predict possible record-setting Gulf of Mexico 'dead zone' 4 Marvin Test Solutions Demonstrates Next-Generation Armament Test Solutions at Paris Air Show 2 Marvin Test Solutions Demonstrates Next-Generation Armament Test Solutions at Paris Air Show 3 UT Arlington research to benefit quality, flow in 150-mile Integrated Pipeline 2

[0] U-M researcher and colleagues predict possible record-setting Gulf of Mexico 'dead zone'[0] Marvin Test Solutions Demonstrates Next-Generation Armament Test Solutions at Paris Air Show [0] UT Arlington research to benefit quality, flow in 150-mile Integrated Pipeline

... blood test may help doctors better predict whether prostate cancer ... for the disease, researchers at UT Southwestern Medical Center have ... issue of Clinical Cancer Research , UT Southwestern scientists ... 86 percent accuracy which prostate cancer patients will experience a ...

... at the Smithsonian,s National Zoo have performed the ... ( E. ferus przewalskii ; E. caballus ... are a horse species native to China and ... in 1970. Currently, there are approximately 1500 of ...

... the human gene DRD4 is linked to better health ... settled cousins, according to new research by a team ... (UWM). A study by UWM assistant professor Ben ... UNLV shows that a particular version of the gene ...

Cached Biology News:Urologists identify 7 biomarkers that may help pinpoint prostate cancer recurrence 2 First successful reverse vasectomy on endangered species performed at the National Zoo 2 First successful reverse vasectomy on endangered species performed at the National Zoo 3 Did the gene for ADHD help our nomadic ancestors? 2

Urologists identify 7 biomarkers that may help pinpoint prostate cancer recurrence First successful reverse vasectomy on endangered species performed at the National Zoo Did the gene for ADHD help our nomadic ancestors?

... is a small and sensitive single ... both LC and IC. It features a ... Ionization (API) source for outstanding sensitivity and ... with existing LC and IC methods, especially ...

Kit for BASE20/50 dual control unit, includes mounting plate, HOLDER50T, HEATERPAD50, SRTDX temperature probe(s)....

...

... R&D Systems Cell and Tissue Staining Kits ... a broad range of histological and cytological ... primary IgG antibodies manufactured by either R&D ... is based on the formation of the ...

Biology Products:

MSQ Plus Mass Spectrometric Detector from Dionex Corporation Kit for BASE20/50 dual control unit KIT50EHTD from Wave Biotech now part of GE Healthcare DTT; 1,4-Dithiothreitol from Roche Applied Science Anti-Rat HRP-AEC Cell & Tissue Staining Kit from R&D Systems